Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check35 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check50 days agoChange DetectedThe website has been updated to version 2.14.2 on January 29, 2025, following the removal of version 2.14.1 on January 8, 2025.SummaryDifference0.6%
- Check64 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe website has added a new type of intervention in the latest update (v2.14.0) on January 8, 2025, while the previous version (v2.13.3) from December 27, 2024, has removed the same feature.SummaryDifference2%
- Check86 days agoChange DetectedThe status has been updated to 'Completed' as of December 27, 2024, while the previous status 'Active, not recruiting' was removed on November 25, 2024.SummaryDifference1%
Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.